densitometer gel pro analyzer 4.0 Search Results


dual energy x ray absorptiometry dexa analyser  (KUB Technologies Inc)
93
KUB Technologies Inc dual energy x ray absorptiometry dexa analyser
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Dual Energy X Ray Absorptiometry Dexa Analyser, supplied by KUB Technologies Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pmc11830570-163-15-30?v=KUB+Technologies+Inc
Average 93 stars, based on 1 article reviews
dual energy x ray absorptiometry dexa analyser - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
gel-pro analyzer software  (Cybergenetics Corporation)
90
Cybergenetics Corporation gel-pro analyzer software
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Pro Analyzer Software, supplied by Cybergenetics Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/10__1128_slash_mcb__01090___07-108-9-15?v=Cybergenetics+Corporation
Average 90 stars, based on 1 article reviews
gel-pro analyzer software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
aida image analyser 4.18  (Raytest GmbH)
90
Raytest GmbH aida image analyser 4.18
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Aida Image Analyser 4.18, supplied by Raytest GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/10__1530_slash_rep___12___0472-160-11-15?v=Raytest+GmbH
Average 90 stars, based on 1 article reviews
aida image analyser 4.18 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
molecular imager gel doc xr system  (Bio-Rad)
96
Bio-Rad molecular imager gel doc xr system
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Molecular Imager Gel Doc Xr System, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pmc06126208-78-20-30?v=Bio-Rad
Average 96 stars, based on 1 article reviews
molecular imager gel doc xr system - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
sigma gel analysis system  (SPSS Inc)
90
SPSS Inc sigma gel analysis system
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Sigma Gel Analysis System, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pm12297551-82-16-19?v=SPSS+Inc
Average 90 stars, based on 1 article reviews
sigma gel analysis system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gel analyzer v. 1.0  (Biosure Inc)
90
Biosure Inc gel analyzer v. 1.0
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Analyzer V. 1.0, supplied by Biosure Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pm18626088-101-21-28?v=Biosure+Inc
Average 90 stars, based on 1 article reviews
gel analyzer v. 1.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
easy win 32 gel documentation system  (Herolab GmbH)
90
Herolab GmbH easy win 32 gel documentation system
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Easy Win 32 Gel Documentation System, supplied by Herolab GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pm15054106-107-6-13?v=Herolab+GmbH
Average 90 stars, based on 1 article reviews
easy win 32 gel documentation system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gel pro analyzer 4.5 software  (Fotodyne Inc)
90
Fotodyne Inc gel pro analyzer 4.5 software
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Pro Analyzer 4.5 Software, supplied by Fotodyne Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pm15880836-132-15-20?v=Fotodyne+Inc
Average 90 stars, based on 1 article reviews
gel pro analyzer 4.5 software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gel expert software program  (NucleoTech Corporation)
90
NucleoTech Corporation gel expert software program
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Expert Software Program, supplied by NucleoTech Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pmc01502612-70-12-16?v=NucleoTech+Corporation
Average 90 stars, based on 1 article reviews
gel expert software program - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
gel pro analyzer software  (Roper Technologies)
86
Roper Technologies gel pro analyzer software
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Pro Analyzer Software, supplied by Roper Technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pmc12332474-85-8-13?v=Roper+Technologies
Average 86 stars, based on 1 article reviews
gel pro analyzer software - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
pdquest advanced 2 d gel analysis software  (Bio-Rad)
96
Bio-Rad pdquest advanced 2 d gel analysis software
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Pdquest Advanced 2 D Gel Analysis Software, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pmc04753329-140-11-19?v=Bio-Rad
Average 96 stars, based on 1 article reviews
pdquest advanced 2 d gel analysis software - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
gel doc quantity one software version 4 5 0  (Bio-Rad)
93
Bio-Rad gel doc quantity one software version 4 5 0
Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body <t>DEXA</t> analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.
Gel Doc Quantity One Software Version 4 5 0, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/densitometer+gel+pro+analyzer+4%2E0/pm24123596-103-4-10?v=Bio-Rad
Average 93 stars, based on 1 article reviews
gel doc quantity one software version 4 5 0 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body DEXA analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.

Journal: Clinical and Translational Medicine

Article Title: Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1

doi: 10.1002/ctm2.70227

Figure Lengend Snippet: Improvement of bone health and body composition parameters in MyoAAV–C3/384‐treated homozygous DMSXL mice. A group of DMSXL male and female homozygous mice at age P5 received a systemic injection of MyoAAV vectors carrying Cas9 and sgC3/384 pair ( n = 7), and underwent whole‐body DEXA analysis at 16 weeks of age. Control animals were wild‐types (WT, n = 16) and untreated DMSXL homozygous mice (NT, n = 14) of both sexes. All data are represented as mean ± SEM and individual data points; data from male (open symbols) and female (filled symbols) mice are pooled. (A–C) Bone health parameters: bone mineral density (BMD) (A), bone mineral content (BMC) (B) and bone area (C). (A) BMD: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.595, df = 14, * p = .02. (B) BMC: MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 3.371, df = 15, ** p = .004. (C) Bone area, WT vs. NT, Mann–Whitney test, U = 53, * p = .013; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 4.25, df = 16, *** p = .0006. (D–F) Body composition parameters: fat tissue percentage (D), lean tissue percentage (E) and fat/lean mass ratio (adiposity index, F). (D) Fat tissue %: WT vs. NT, Mann–Whitney test, U = 46, ** p = .0052; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (E) Lean tissue %: WT vs. NT, Mann–Whitney test, U = 45, ** p = .0045; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.684, df = 17.14, * p = .015. (F) Adiposity index, WT vs. NT, unpaired t ‐test with Welch's correction, t = 3.265, df = 15.37, ** p = .0051; MyoAAV–C3/384 vs. NT, unpaired t ‐test with Welch's correction, t = 2.643, df = 16.41, * p = .017.

Article Snippet: Bone health and body composition were comprehensively evaluated at the age of 4 months using Dual Energy X‐ray Absorptiometry (DEXA) analyser (The PARAMETER™ XPERT® 40 Cabinet X‐ray System, T00261_A 9.2019; Kubtec Scientific, 111 Research Drive Stratford, CT 06615, USA).

Techniques: Injection, Control, MANN-WHITNEY